to the parent 205.93 236.49 (30.56) (12.92%) 1,044.79 1,117.52 (72.73) (6.51%) Earnings per share (EPS) 0.12 0.14 (0.02) (12.92%) 0.63 0.67 (0.04) (6.51%) Raw water costs 52% Tap water costs 36% Rental
were back on track with 44.5% growth YoY and 3.4% growth QoQ. - In Q1’19, the Company maintained its leadership position with total market share of 31.1% in Brain and Body Boost (“BBB”) products which
= Translation = Management Discussion and Analysis for Interim Business Operations The Information of Share Capital Registration and Entire Business Transfer The Company registered the change of
% Administrative expenses (109.5) (15.3) (512.5) (29.3) 368.0% Finance costs (Interest expenses) (68.6) (9.7) (205.5) (11.7) 200.0% Other income 83.8 11.7 83.8 4.8 0.1% Share of profit (loss) from investment in an
% % Administrative expenses to sales 11.1% 10.7% Finance costs 16.4 16.2 +2% Share of profit (loss) from investment in subsidiaries and joint ventures (1) (1.5) +35% Tax (income) 0 (16) +101% Net profit (loss) major
Public Company Limited’s subsidiary company (“The Company”), Joint Venture Ureka UU co., ltd. (“UU”), in which the company hold 90% of the share. The company plans to increase the shareholding to 99%. On
507mn o Advertising revenue decreased by 56.8% YoY to THB 179mn. o System integration services revenue decreased by 1.5% YoY to THB 328mn. Recorded a share of loss from investment in joint ventures and
consolidate financial statement as follows: • Income from GLANDRT leasehold asset divestment amount THB 270 mn was recognized in share of profit from associated companies • GLANDRT dissolve expense amount THB
consolidate financial statement as follows: • Income from GLANDRT leasehold asset divestment amount THB 270 mn was recognized in share of profit from associated companies • GLANDRT dissolve expense amount THB
paid an interim dividend of THB 523m in Q4/19 (THB 0.65/share). For the year 2018 the company paid full dividends of THB 1,610m (THB 2.00/share). An interim dividend paid of THB 805m in Q4/18 and the